Vancouver, BC, July 15, 2019--DelMar Pharmaceuticals, Inc.(NASDAQ: DMPI), a biopharmaceutical company focused on the development of novel cancer therapies, announced that it has initiated the process of relocating the Company's headquarters from Vancouver, British Columbia to San Diego, CA.
|